Ruth E. Brown

5.0k total citations · 1 hit paper
109 papers, 3.7k citations indexed

About

Ruth E. Brown is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Surgery. According to data from OpenAlex, Ruth E. Brown has authored 109 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Economics and Econometrics and 16 papers in Surgery. Recurrent topics in Ruth E. Brown's work include Diabetes Management and Research (22 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Diabetes Treatment and Management (18 papers). Ruth E. Brown is often cited by papers focused on Diabetes Management and Research (22 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Diabetes Treatment and Management (18 papers). Ruth E. Brown collaborates with scholars based in Canada, United States and United Kingdom. Ruth E. Brown's co-authors include Jennifer L. Kuk, Ronnie Aronson, John Hutton, Dennis A. Revicki, Bryan R. Luce, Annamaria Cerulli, Carlos Fernández Vidaurre, Stephanie Manson, Richard J. Willke and J.R. Cook and has published in prestigious journals such as Diabetes Care, Nature Reviews Drug Discovery and Diabetes.

In The Last Decade

Ruth E. Brown

106 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report

2005 532 citations Scott D. Ramsey, Richard J. Willke et al. Value in Health profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ruth E. Brown	851	635	546	508	433	109	3.7k
Neil Hawkins	1.1k 1.3×	345 0.5×	307 0.6×	923 1.8×	355 0.8×	150	5.5k
Rajesh Balkrishnan	526 0.6×	266 0.4×	633 1.2×	445 0.9×	571 1.3×	158	4.6k
Joseph Menzin	584 0.7×	197 0.3×	334 0.6×	424 0.8×	350 0.8×	127	3.7k
Ken Farrington	692 0.8×	556 0.9×	347 0.6×	1.4k 2.8×	568 1.3×	252	7.0k
Giovannella Baggio	279 0.3×	905 1.4×	529 1.0×	800 1.6×	230 0.5×	108	4.1k
Fiona Clement	1.1k 1.3×	291 0.5×	233 0.4×	556 1.1×	1.2k 2.8×	179	4.4k
Andrew Clegg	440 0.5×	913 1.4×	401 0.7×	1.9k 3.7×	694 1.6×	135	5.5k
Helle Wallach‐Kildemoes	438 0.5×	220 0.3×	339 0.6×	582 1.1×	389 0.9×	34	3.8k
Feng Lin	300 0.4×	436 0.7×	1.3k 2.4×	1.1k 2.2×	510 1.2×	173	7.1k
Nicole Mittmann	882 1.0×	215 0.3×	151 0.3×	521 1.0×	391 0.9×	190	4.2k

Countries citing papers authored by Ruth E. Brown

Since Specialization

Citations

This map shows the geographic impact of Ruth E. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Brown more than expected).

Fields of papers citing papers by Ruth E. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth E. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Brown. The network helps show where Ruth E. Brown may publish in the future.

Co-authorship network of co-authors of Ruth E. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth E. Brown. A scholar is included among the top collaborators of Ruth E. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth E. Brown. Ruth E. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Ruth E.. (2025). Evaluating the Effectiveness and Long-term Outcomes of Roux-en-Y Gastric Bypass vs Gastric Sleeve Bariatric Surgery in Obese and Diabetic Patients: Systematic Review. Journal of the American College of Surgeons. 241(6). 1148–1159.

Weisman, Alanna, et al.. (2023). Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data. Canadian Journal of Diabetes. 48(1). 44–52.e5. 4 indexed citations

Aronson, Ronnie, Ruth E. Brown, Alexander Abitbol, et al.. (2020). The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 Diabetes. Diabetes Technology & Therapeutics. 23(1). 31–40. 19 indexed citations

Abitbol, Alexander, et al.. (2019). Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study. Canadian Journal of Diabetes. 43(7). 504–509.e1. 13 indexed citations

Li, Aihua, et al.. (2019). Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(5). 286–294. 30 indexed citations

Harwood, Brad, et al.. (2014). The effect of tendon vibration on motor unit activity, intermuscular coherence and force steadiness in the elbow flexors of males and females. Acta Physiologica. 211(4). 597–608. 35 indexed citations

Canning, Karissa L., Ruth E. Brown, Veronica Jamnik, & Jennifer L. Kuk. (2013). Relationship Between Obesity and Obesity-Related Morbidities Weakens With Aging. The Journals of Gerontology Series A. 69(1). 87–92. 58 indexed citations

Carroll, Stuart, et al.. (2011). PIN35 Costs of Managing Genital Warts in the UK. Value in Health. 14(7). A271–A271. 1 indexed citations

Pan, Feng, et al.. (2011). Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis: A Canadian Perspective. Value in Health. 14(5). 652–656. 25 indexed citations

10.

Baker, Timothy, et al.. (2011). Cost-effectiveness analysis of valsartan versus losartan and the effect of switching. Journal of Medical Economics. 15(2). 253–260. 5 indexed citations

11.

Burnier, Michel, et al.. (2009). Issues in blood pressure control and the potential role of single-pill combination therapies. International Journal of Clinical Practice. 63(5). 790–798. 35 indexed citations

12.

Ramsey, Scott D., Richard J. Willke, Andrew Briggs, et al.. (2005). Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report. Value in Health. 8(5). 521–533. 532 indexed citations breakdown →

13.

Brown, Ruth E., et al.. (2004). Hepatitis B Management Costs in France, Italy, Spain, and the United Kingdom. Journal of Clinical Gastroenterology. 38(10 Suppl 3). S169–S174. 18 indexed citations

14.

Drummond, Michael, Ruth E. Brown, A. Mark Fendrick, et al.. (2003). Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making. Value in Health. 6(4). 407–416. 90 indexed citations

15.

Hutton, John, et al.. (1996). A New Decision Model for Cost-Utility Comparisons of Chemotherapy in Recurrent Metastatic Breast Cancer. PharmacoEconomics. 9(Supplement 2). 8–22. 87 indexed citations

16.

Brown, Ruth E., et al.. (1996). Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology. 8(1). 19–27. 2 indexed citations

17.

Revicki, Dennis A., et al.. (1995). Modelling the Cost Effectiveness of Antidepressant Treatment in Primary Care. PharmacoEconomics. 8(6). 524–540. 49 indexed citations

18.

Halpern, Michael T., Ruth E. Brown, Dennis A. Revicki, & Alkis Togias. (1994). An example of using computer simulation to predict pharmaceutical costs and outcomes. Winter Simulation Conference. 850–855. 3 indexed citations

19.

Hatziandreu, Evridiki J., et al.. (1994). Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with Dothiepin. PharmacoEconomics. 5(3). 249–264. 69 indexed citations

20.

Rossiter, Louis F., et al.. (1989). Medicare's expanded choices program: issues and evidence from the HMO experience.. PubMed. 10. 3–40. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact